Since the US 'good news' OBD down 23%14 Nov 2023 15:35
No one doubts the science and medical institutions relationship, what is missing is how and when OBD are moneytising the service/product. That's why shareholder's are selling, they invest to make money. OBD needs to list in the US on a main market, it has zero credibiity as OTC as it is now. It's like AIM only much worse.
Hopefully someone will educate them at this investor meeting.
I've kept some shares in my p/folio just so I don't forget OBD entirely, if they wise up and make the business case as good as the science the SP will rise, stay like it is and they sink.
Potential is fine but how many times do we hear that - too many times, it means nothing
How and when exactly are they going to pull in cash? Thats what investors want to hear.